Eating disorders have a high mortality rate compared with other mental health conditions, but many people struggle to access treatment. According to a report by STRIPED, the Academy for Eating Disorders and Deloitte Access Economics, 28.8 million Americans alive in 2018 and 2019 will have an eating disorder at some point in their lives.
Equip, a virtual eating disorder treatment company, aims to...
Digital health investment has slowed so far this year following blockbuster funding in 2021. Mental and behavioral health startups, which drew plenty of investor dollars in the wake of the COVID-19 pandemic, aren't immune from the downturn.
There was a lot of hype surrounding virtual mental health tools during the pandemic, and a variety of startups focused on lower-acuity conditions like anxiety...
In the midst of controversy surrounding the digital mental health company's prescribing practices and a week after it replaced its CEO, Cerebral revealed a transformation plan focused on growth and patient experience.
The program, called Cerebral Core, includes objectives to review quality practices as well as improve the user and clinician experience.
The company said it plans to add in-network...
Cerebral CEO and cofounder Kyle Robertson is leaving his position at the digital mental health company amid growing controversy over its prescribing practices, particularly for controlled substances like Adderall.
Dr. David Mou, who has served as Cerebral's president and chief medical officer, will be taking the reins as CEO effective immediately. Mou added the president role earlier this month....
Mental health benefits provider Spring Health is expanding into the family and pediatric space with its acquisition of Weldon.
Weldon offers mental wellness guidance to parents through chats with therapists, social workers and parenting coaches as well as group support with other parents and educational content. It includes topics like sleep, tantrums, grief, screen time and overall child...
Cerebral will stop prescribing most controlled substances to new and existing patients, the embattled digital mental health company confirmed to Insider.
According to an email sent to staff on Monday, Cerebral CEO Kyle Robertson said the company would halt prescriptions of controlled substances like Adderall and Xanax for new patients starting May 20 and for existing patients starting October 15...
Mental health EHR Osmind scored $40 million in a Series B funding round led by DFJ Growth.
Other participants include Susa Ventures, General Catalyst, Future Ventures, Tiger Global, Pear VC and angels Lachy Groom, Brent Saunders, Helena Goodman and Ariel Katz.
Osmind offers an EHR tailored to clinicians and researchers using and studying ketamine and other psychedelics, as well as transcranial...
Cerebral is under investigation for possible violations of the Controlled Substances Act as the digital mental health company faces increasing scrutiny over its prescribing practices for medications like Adderall.
As first reported by Insider, Cerebral confirmed it had received a grand jury subpoena from the U.S. Attorney’s Office for the Eastern District of New York on the evening of May 4. That...
Amid growing controversy over Cerebral's prescribing practices, the digital mental health company will pause prescriptions of controlled substances like Adderall and Ritalin for new patients.
The suspension will begin Monday, May 9, though existing patients can continue to receive their prescribed medications.
"It is regrettable that a helpful class of medication that is considered a first-line...
Editor's note: This story has been updated to reflect that Cerebral does not offer services to patients under the age of 18.
BOSTON – Cerebral Chief Medical Officer Dr. David Mou on Sunday defended the digital mental health company's prescribing practices, but mistakes have been made, especially in the area of marketing, he admitted during the American Telemedicine Association Association's...
_8_32.jpeg?itok=mU58uQog "A piggy bank next to a stethoscope and a pile of coins")
